Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Result of AGM

7th Nov 2018 10:42

RNS Number : 6405G
Craneware plc
07 November 2018
 

Craneware plc

("Craneware", "the Group" or the "Company")

Result of AGM

 

7 November 2018 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, is pleased to announce that at its Annual General Meeting held yesterday, all resolutions were duly passed.

 

The proxy voting results are included below.

 

Resolution

For

Against

Discretion to Chairman and Third party

Withheld

Total

01

14,155,187

0

1,610

2,114

14,158,911

02

13,685,555

471,246

1,610

500

14,158,911

03

13,993,525

17,835

1,610

145,941

14,158,911

04

13,666,828

490,473

1,610

0

14,158,911

05

14,138,179

19,122

1,610

0

14,158,911

06

14,124,953

32,348

1,610

0

14,158,911

07

9,816,543

4,340,758

1,610

0

14,158,911

08

14,137,743

19,558

1,610

0

14,158,911

09

14,157,179

122

1,610

0

14,158,911

10

8,226,805

5,929,996

1,610

500

14,158,911

11

13,148,275

1,009,026

1,610

0

14,158,911

12

14,141,944

15,357

1,610

0

14,158,911

13

14,157,179

122

1,610

0

14,158,911

14

14,155,999

1,302

1,610

0

14,158,911

15

13,057,491

1,099,810

1,610

0

14,158,911

16

13,747,429

146,112

1,600

263,770

14,158,911

 

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO / Craig Preston, CFO

Peel Hunt (NOMAD and Joint Broker)

+44 (0)20 7418 8900

Dan Webster/ George Sellar / Guy Pengelley

Investec Bank (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb/ Sebastian Lawrence/ Henry Reast

Alma (Financial PR)

+44 (0)7779 664 584

Caroline Forde/ Robyn Fisher/ Josh Royston

 

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 Learn more at www.craneware.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RAGBGBDBRXGBGIR

Related Shares:

Craneware
FTSE 100 Latest
Value8,762.88
Change-9.50